<p>Townes-Brocks syndrome (TBS, MIM#107480) is an autosomal dominant disorder linked to <i>SALL1</i> alterations and characterized by a clinical triad (anorectal, thumb, and external-ear malformations), along with variable features. Renal failure and deafness can occur at any age, making follow-up essential. Some genotype-phenotype correlations have been suggested but data are limited. We collected clinical and molecular data from 49 patients with a <i>SALL1</i> (likely) pathogenic variant identified in our laboratory or through collaborations, and reviewed the 207 <i>SALL1</i> related-TBS patients previously reported in the literature. We performed statistical analysis to study genotype-phenotype correlations based notably on the variant position in relation to the glutamine-rich region. In our series, 25% of individuals presented with the clinical triad compared to 49.7% in the literature. The deafness frequency was similar (65%). Renal failure was diagnosed in 39.6% of our patients compared to 29.3% in the literature. Developmental delay or intellectual disability affected 9% of patients. Of the 22 <i>SALL1</i> variants in our series, 35% were located upstream of the glutamine-rich region, compared to 6.5% in the literature. Statistical analysis was performed on all patients, of which 26 and 200 carried a variant upstream and downstream of the glutamine-rich region, respectively. A significant increase in deafness, dysplastic ear, and thumb malformations and a significant decrease in renal failure were observed in the individuals carrying a variant located downstream of the region, but the patients were significantly younger. Future studies should aim to elucidate the complex pathophysiological mechanisms and prognosis of TBS, functionally and prospectively.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Townes-Brocks syndrome: genotype-phenotype correlations of SALL1 variants in our series and the literature

  • Fiona Leduc,
  • Perrine Brunelle,
  • Fabienne Escande,
  • Nassima Ramdane,
  • Laurence Bellengier,
  • Léa Giacomello,
  • Christine Lefevre,
  • Aurélie Mezel,
  • Charlotte Samaille,
  • Rony Sfeir,
  • Philippine Toulemonde,
  • Catheline Vilain,
  • Sebastian Neuens,
  • Julie Soblet,
  • Elise Schaefer,
  • Olivia Boyer,
  • Radka Stoeva,
  • Alissandre Lecordier,
  • Mathilde Nizon,
  • Bertrand Isidor,
  • Solène Conrad,
  • Laëtitia Lambert,
  • Mélanie Berard-Cloteau,
  • Maria K Haanpää,
  • Minna Toivonen,
  • Sahar Mansour,
  • Mohamed Wafik,
  • Shereen Tadros,
  • Abid Sharif,
  • Lewis Darnell,
  • Khaoula Zaafrane-Khachnaoui,
  • Lucile Riera-Navarro,
  • Fanny Morice-Picard,
  • Klaus Dieterich,
  • Alicia Coudert,
  • Sophie Blesson,
  • Anne-Marie Guerrot,
  • Sacha Weber,
  • Kara Ranguin,
  • Sabine Sigaudy,
  • Olga Glazunova,
  • Geneviève Baujat,
  • Sarah Grotto,
  • Sébastien Moutton,
  • Audrey Putoux,
  • Hélène Vallin,
  • Sylvie Manouvrier-Hanu,
  • Catherine Vincent-Delorme,
  • Florence Petit,
  • Clémence Vanlerberghe

摘要

Townes-Brocks syndrome (TBS, MIM#107480) is an autosomal dominant disorder linked to SALL1 alterations and characterized by a clinical triad (anorectal, thumb, and external-ear malformations), along with variable features. Renal failure and deafness can occur at any age, making follow-up essential. Some genotype-phenotype correlations have been suggested but data are limited. We collected clinical and molecular data from 49 patients with a SALL1 (likely) pathogenic variant identified in our laboratory or through collaborations, and reviewed the 207 SALL1 related-TBS patients previously reported in the literature. We performed statistical analysis to study genotype-phenotype correlations based notably on the variant position in relation to the glutamine-rich region. In our series, 25% of individuals presented with the clinical triad compared to 49.7% in the literature. The deafness frequency was similar (65%). Renal failure was diagnosed in 39.6% of our patients compared to 29.3% in the literature. Developmental delay or intellectual disability affected 9% of patients. Of the 22 SALL1 variants in our series, 35% were located upstream of the glutamine-rich region, compared to 6.5% in the literature. Statistical analysis was performed on all patients, of which 26 and 200 carried a variant upstream and downstream of the glutamine-rich region, respectively. A significant increase in deafness, dysplastic ear, and thumb malformations and a significant decrease in renal failure were observed in the individuals carrying a variant located downstream of the region, but the patients were significantly younger. Future studies should aim to elucidate the complex pathophysiological mechanisms and prognosis of TBS, functionally and prospectively.